Pyxis Oncology (PYXS) EPS (Diluted) (2021 - 2026)
Pyxis Oncology (PYXS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.15 |
| 10 | Pyxis Oncology | 196.77 Mn | 163.78 Mn | - | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.41 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -0.50 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -0.47 |
| Mar 31, 2023 | -0.72 |
| Dec 31, 2022 | -1.07 |
| Sep 30, 2022 | -1.25 |
| Jun 30, 2022 | -1.20 |
| Mar 31, 2022 | -0.98 |
| Dec 31, 2021 | -4.96 |
| Sep 30, 2021 | -29.32 |
| Jun 30, 2021 | -4.03 |